莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002166 莱茵生物

已收盘 12-25 15:00:00

{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":7.76,"timestamp":1735110192000,"preClose":7.96,"halted":0,"volume":11951271,"delay":0,"floatShares":517000000,"shares":742000000,"eps":0.1931,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.2,"latestTime":"12-25 15:00:00","open":7.98,"high":8.02,"low":7.7,"amount":93452000,"amplitude":0.0402,"askPrice":7.77,"askSize":67,"bidPrice":7.76,"bidSize":878,"shortable":0,"etf":0,"ttmEps":0.1931,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735176600000},"adr":0,"adjPreClose":7.96,"symbolType":"stock","openAndCloseTimeList":[[1735090200000,1735097400000],[1735102800000,1735110000000]],"highLimit":8.76,"lowLimit":7.16,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741986825,"pbRate":1.94,"roa":"--","roe":"3.28%","epsLYR":0.11,"committee":0.65727,"marketValue":5758000000,"floatMarketCap":4008000000,"peRate":40.186431,"changeRate":-0.0251,"turnoverRate":0.0231,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-27。"},"requestUrl":"/m/hq/s/002166/tweets","defaultTab":"tweets","newsList":[{"id":"2492341224","title":"莱茵生物最新公告：取得金融机构股票回购贷款承诺函","url":"https://stock-news.laohu8.com/highlight/detail?id=2492341224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492341224?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:00","pubTimestamp":1734696050,"startTime":"0","endTime":"0","summary":"莱茵生物公告，公司收到中信银行股份有限公司桂林分行出具的《贷款承诺函》，承诺贷款额度最高不超过6,000万元人民币，贷款期限为三年，专项用于回购上市公司股票。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000038694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0046","BK0028","BK0239","002166","BK0168"],"gpt_icon":0},{"id":"2491316627","title":"华鑫证券：给予莱茵生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2491316627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491316627?lang=zh_cn&edition=full","pubTime":"2024-12-13 14:00","pubTimestamp":1734069648,"startTime":"0","endTime":"0","summary":"华鑫证券有限责任公司胡博新,孙山山,张倩近期对莱茵生物进行研究并发布了研究报告《公司深度报告：天然甜味剂龙头，合成生物再拓空间》，本报告对莱茵生物给出买入评级，当前股价为8.34元。车间全面达产后预计产量1000吨/年，年产值超10亿元。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300019491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","161027"],"gpt_icon":0},{"id":"2490760997","title":"莱茵生物股票索赔：实控人操纵证券市场受处罚，投资者索赔案启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2490760997","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490760997?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:54","pubTimestamp":1733709240,"startTime":"0","endTime":"0","summary":"　　近日，代理过多件重大影响案件的江苏博爱星律师事务所章祥兵律师特别提示，莱茵生物（维权）实控人操纵证券市场受处罚，投资者索赔案启动。　　2024年12月5日，桂林莱茵生物科技股份有限公司发布公告称，公司收到实际控制人秦本军先生通知，获悉其收到中国证监会下发的《行政处罚决定书》。　　目前，章祥兵律师正在代理莱茵生物受损投资者索赔诉讼工作，管辖法院南宁市中级人民法院。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-12-09/doc-incyvnxz2854363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002166","BK0168","BK0239","BK0028","BK0046","BK0174"],"gpt_icon":0},{"id":"2489540258","title":"操纵证券市场，莱茵生物实控人秦本军被罚禁入五年","url":"https://stock-news.laohu8.com/highlight/detail?id=2489540258","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489540258?lang=zh_cn&edition=full","pubTime":"2024-12-06 18:02","pubTimestamp":1733479320,"startTime":"0","endTime":"0","summary":"来源：@究竟视频微博    【操纵证券市场，#莱茵生物（维权）实控人秦本军被罚禁入五年#】因操控证券市场长达7个月，涉及资金1.2亿元，涉及28个资金账户，“莱茵生物”实际控制人秦本军被罚。同日，莱茵生物发布秦本军辞任公告。辞职之前，秦本军再次进行了股权质押，持股质押比例达到66.41%。值得注意的是，今年以来，公司披露涉及股权质押的公告数量激增。 \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2024-12-06/doc-incypnsm1960403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0028","BK0174","002166","BK0239","BK0168"],"gpt_icon":0},{"id":"2489279459","title":"被罚没276万元，禁入证券市场5年！莱茵生物实控人辞去董事长等职","url":"https://stock-news.laohu8.com/highlight/detail?id=2489279459","media":"立刻财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489279459?lang=zh_cn&edition=full","pubTime":"2024-12-05 20:44","pubTimestamp":1733402640,"startTime":"0","endTime":"0","summary":"桂林莱茵生物科技股份有限公司实控人秦本军因操纵证券市场被证监会罚没276.37万元，并被采取5年证券市场禁入措施后，辞去公司董事长、总经理等职。12月4日，莱茵生物公告称，公司董事会收到董事长、总经理秦本军的书面辞职报告。莱茵生物进一步指出。莱茵生物同日公告显示，2023年5月10日，秦本军收到证监会的《立案告知书》，因涉嫌操纵证券市场，证监会决定对其立案调查。2023年莱茵生物净利润为0.83亿元，同比减少53.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-05/doc-incympzk9540814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0168","BK0046","BK0028","BK0174","002166"],"gpt_icon":0},{"id":"2489710862","title":"莱茵生物实控人因证券操纵收200万罚单","url":"https://stock-news.laohu8.com/highlight/detail?id=2489710862","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489710862?lang=zh_cn&edition=full","pubTime":"2024-12-05 11:08","pubTimestamp":1733368080,"startTime":"0","endTime":"0","summary":"　　2024年12月5日，桂林莱茵生物（维权）科技股份有限公司公告称，公司实际控制人秦本军先生收到到中国证监会的《行政处罚决定书》。　　罗建欣律师代理的部分投资者诉莱茵生物声控人证券操纵案目前正在有序推进，索赔条件暂定为：2021年4月14日至2021年11月15日期间买入股票，且存在损失，不论是否卖空均可参与索赔；索赔条件最终以法院认定为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-12-05/doc-incyknpv3184178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0168","161027","002166","BK0239","BK0174","BK0046"],"gpt_icon":0},{"id":"2488192987","title":"莱茵生物最新公告：实际控制人收到行政处罚决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2488192987","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488192987?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:30","pubTimestamp":1733322654,"startTime":"0","endTime":"0","summary":"莱茵生物公告，实际控制人收到行政处罚决定书。根据决定书，秦本军构成操纵证券市场的行为，被没收违法所得69.09万元，并处以207.28万元罚款。同时，秦本军被采取5年证券市场禁入措施。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400039894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0046","BK0174","002166","BK0239"],"gpt_icon":0},{"id":"2488196888","title":"莱茵生物（002166）股东秦本军质押600万股，占总股本0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488196888","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488196888?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:20","pubTimestamp":1733318402,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物12月4日公开信息显示，股东秦本军向华夏银行股份有限公司桂林分行合计质押600.0万股，占总股本0.81%。莱茵生物主营业务：天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400039397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0239","BK0168","BK0028","BK0174","BK0046"],"gpt_icon":0},{"id":"2488493164","title":"莱茵生物：关于公司董事长、总经理辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2488493164","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488493164?lang=zh_cn&edition=full","pubTime":"2024-12-04 19:40","pubTimestamp":1733312400,"startTime":"0","endTime":"0","summary":"2024年12月4日，桂林莱茵生物科技股份有限公司董事会收到董事长、总经理秦本军先生的书面辞职报告。秦本军先生因被中国证券监督管理委员会采取5年证券市场职务禁入措施，特向公司董事会申请辞去公司第六届董事会董事长、总经理及董事会提名委员会委员职务，辞职后其不在公司担任任何职务。秦本军先生辞去上述职务后，未导致公司董事会人数低于法定最低人数，不会影响公司董事会的正常运行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-04/doc-incyhynr0635419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0174","BK0046","BK0168","BK0239","BK0028","002166"],"gpt_icon":0},{"id":"2488932161","title":"莱茵生物(002166.SZ)总经理秦本军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2488932161","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488932161?lang=zh_cn&edition=full","pubTime":"2024-12-04 19:35","pubTimestamp":1733312113,"startTime":"0","endTime":"0","summary":"莱茵生物(002166.SZ)发布公告，2024年12月4日，公司董事会收到董事长...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/15.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/15.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0168","BK0046","BK0028","BK0174","002166"],"gpt_icon":0},{"id":"2488167307","title":"莱茵生物：董事长、总经理秦本军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167307","media":"证券","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488167307?lang=zh_cn&edition=full","pubTime":"2024-12-04 19:27","pubTimestamp":1733311620,"startTime":"0","endTime":"0","summary":"证券时报e公司讯，莱茵生物（维权）(002166)12月4日晚间公告，秦本军因被中国证监会采取5年证券市场职务禁入措施，申请辞去公司第六届董事会董事长、总经理及董事会提名委员会委员职务，辞职后其不在公司担任任何职务。为保证公司日常经营决策的顺利开展，由公司半数以上董事共同推举董事谢永富代行董事长、总经理及董事会提名委员会委员职务，直至选举产生新任董事长为止。（文章来源：证券时报网）\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-04/doc-incyieum3730854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002166","BK0168","BK0239","BK0028","BK0046","BK0174"],"gpt_icon":0},{"id":"2488169979","title":"莱茵生物最新公告：董事长、总经理秦本军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2488169979","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488169979?lang=zh_cn&edition=full","pubTime":"2024-12-04 19:09","pubTimestamp":1733310583,"startTime":"0","endTime":"0","summary":"莱茵生物公告，公司董事会于2024年12月4日收到董事长、总经理秦本军的书面辞职报告。秦本军因被中国证券监督管理委员会采取5年证券市场职务禁入措施，申请辞去公司第六届董事会董事长、总经理及董事会提名委员会委员职务，辞职后其不在公司担任任何职务。秦本军的辞职报告自送达董事会时生效。公司将根据《公司法》《公司章程》的相关规定尽快增补董事、聘任总经理。在新任董事长选举产生前，由董事谢永富代行董事长、总经理及董事会提名委员会委员职务。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400033862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0046","BK0028","BK0239","002166","BK0168"],"gpt_icon":0},{"id":"2488166259","title":"莱茵生物：董事长、总经理秦本军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2488166259","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488166259?lang=zh_cn&edition=full","pubTime":"2024-12-04 19:09","pubTimestamp":1733310549,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0168","BK0239","BK0028","BK0174","BK0046","002166"],"gpt_icon":0},{"id":"2485105746","title":"莱茵生物（002166）301.86万股限售股将于11月21日解禁，占总股本0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485105746","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485105746?lang=zh_cn&edition=full","pubTime":"2024-11-21 08:04","pubTimestamp":1732147463,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，莱茵生物于11月21日将有301.86万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.41%。本次解禁后，公司还有2.25亿股限售股份，占总股本30.38%。莱茵生物主营业务：天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100005997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0168","BK0239","BK0028","BK0046","002166"],"gpt_icon":0},{"id":"2484178974","title":"莱茵生物（002166）股东秦本军质押400万股，占总股本0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484178974","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484178974?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:22","pubTimestamp":1732044121,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物11月20日公开信息显示，股东秦本军向华夏银行股份有限公司桂林分公司合计质押400.0万股，占总股本0.54%。莱茵生物主营业务：天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000004711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0168","BK0174","BK0239","BK0046"],"gpt_icon":0},{"id":"2480381310","title":"华鑫证券：给予莱茵生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480381310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480381310?lang=zh_cn&edition=full","pubTime":"2024-11-03 09:25","pubTimestamp":1730597125,"startTime":"0","endTime":"0","summary":"华鑫证券有限责任公司胡博新,孙山山,张倩近期对莱茵生物进行研究并发布了研究报告《公司事件点评报告：植提业务稳步增长，产能建设按计划落地》，本报告对莱茵生物给出买入评级，当前股价为7.99元。　　莱茵生物　　事件　　2024年10月30日，莱茵生物发布2024年三季度报告。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300000259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002166"],"gpt_icon":0},{"id":"2480014304","title":"莱茵生物：10月31日接受机构调研，华鑫证券、上海杭贵投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2480014304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480014304?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:47","pubTimestamp":1730425627,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月31日莱茵生物发布公告称公司于2024年10月31日接受机构调研，华鑫证券孙山山 张倩 张卉琦、上海杭贵投资饶欣莹、深圳市果盈资产林晓珊、北京泾谷私募基金高艺、宁波三登投资倪娜、北京大家投资张翔、北京橡果资产魏鑫、上海丰仓股权投资基金路永光、浙商证券杜宛泽、天风国际冯梦媛、财通证券王子昂、野村东方国际证券周悦琅、东北证券陈科诺、鸿运私募基金高波、深圳中天汇富基金慕陶、天治基金王策源参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100012289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","161027","BK0046","BK0168","BK0028","BK0239","002166"],"gpt_icon":0},{"id":"2480109989","title":"莱茵生物（002166）2024年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2480109989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480109989?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:39","pubTimestamp":1730414387,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期莱茵生物发布2024年三季报。截至本报告期末，公司营业总收入11.7亿元，同比上升31.61%，归母净利润1.02亿元，同比上升148.46%。按单季度数据看，第三季度营业总收入4.44亿元，同比上升17.96%，第三季度归母净利润3672.86万元，同比上升680.75%。本报告期莱茵生物盈利能力上升，毛利率同比增幅22.55%，净利率同比增幅51.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100007161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0},{"id":"2479703222","title":"天风证券：给予莱茵生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479703222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479703222?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:16","pubTimestamp":1730369782,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司吴立,杨松近期对莱茵生物进行研究并发布了研究报告《24前三季度植提业务大幅增长，合成生物车间投产夯实技术壁垒》，本报告对莱茵生物给出买入评级，当前股价为8.15元。公司植物提取业务稳健增长，看好合成生物车间核心产品商业化前景，以及对未来工业大麻市场的快速提升有信心，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100037868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","601162"],"gpt_icon":0},{"id":"2479790758","title":"图解莱茵生物三季报：第三季度单季净利润同比增680.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479790758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479790758?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:58","pubTimestamp":1730311119,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物2024年三季报显示，公司主营收入11.7亿元，同比上升31.61%；归母净利润1.02亿元，同比上升148.46%；扣非净利润1.05亿元，同比上升2789.46%；其中2024年第三季度，公司单季度主营收入4.44亿元，同比上升17.96%；单季度归母净利润3672.86万元，同比上升680.75%；单季度扣非净利润3916.58万元，同比上升11411.63%；负债率36.91%，投资收益717.93万元，财务费用2483.46万元，毛利率28.16%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100003050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":0.0284},{"period":"3month","weight":0.1148},{"period":"6month","weight":0.174},{"period":"1year","weight":0.0463},{"period":"ytd","weight":0.0517}],"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","perCapita":"9060股","boardName":"医药制造业","registeredCapital":"74198万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0387},{"period":"3month","weight":0.1717},{"period":"6month","weight":0.152},{"period":"1year","weight":0.1626},{"period":"ytd","weight":0.1407}],"survey":"　　桂林莱茵生物科技股份有限公司主要从事天然健康产品业务,主要产品是罗汉果提取物、甜叶菊提取物、工业大麻提取物、茶叶提取物及其他保健护肤提取物。公司先后获得“植物提取物优质供应商”、“中国质量诚信企业”、“中国农业企业500强”等殊荣，2023年顺利通过“国家级专精特新小巨人企业”、“农业产业化国家重点龙头企业”等荣誉复审，作为植物提取行业绿色转型升级的示范标杆企业更是取得了“国家级绿色工厂”的荣誉称号。","serverTime":1735135656213,"listedPrice":9.89,"stockholders":"57010人(较上一季度减少4.22%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}